- Forums
- ASX - By Stock
- DYL
- Ann: Appendix 5B March 2023 Quarterly Cashflow
Ann: Appendix 5B March 2023 Quarterly Cashflow, page-41
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DYL (ASX) to my watchlist
|
|||||
Last
$1.43 |
Change
-0.028(1.89%) |
Mkt cap ! $1.390B |
Open | High | Low | Value | Volume |
$1.45 | $1.45 | $1.43 | $911.6K | 635.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 110669 | $1.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.43 | 13707 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 110039 | 1.425 |
19 | 130038 | 1.420 |
14 | 91582 | 1.415 |
13 | 110167 | 1.410 |
4 | 19831 | 1.405 |
Price($) | Vol. | No. |
---|---|---|
1.430 | 7428 | 8 |
1.435 | 54745 | 22 |
1.440 | 125700 | 20 |
1.445 | 176660 | 15 |
1.450 | 88431 | 11 |
Last trade - 11.47am 16/07/2024 (20 minute delay) ? |
Featured News
DYL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online